Skip to main content
. 2023 May 24;9(2):e002945. doi: 10.1136/rmdopen-2022-002945

Table 5.

Level of conclusion for associations between inflammatory signs and altered pain perception (pain sensitivity and neuropathic-like pain)

Associations Level of evidence Level of conclusion
Inflammatory signs—pain sensitivity A1 A2 B C D
Effusion/synovitis Neogi et al50[+] Petersen et al49[+] Sofat et al47[ns] 2
BMLs Neogi et al50[ns] Sofat et al47[ns] 2
Pro-inflammatory cytokines 4
 IL-1β Lee et al44[ns]
 IL-6 Imamura et al43[ns]
Lee et al44[+]
 TNF-α Imamura et al43[ns]
Lee et al44[+]
CRP Arendt-Nielsen et al42[+] Lee et al44[+] 3
Inflammatory signs—neuropathic-like pain
Effusion/synovitis Radojčić et al46[+] 4
Pro-inflammatory cytokines 4
 IL-1β Li et al45[ns]
Tchetina et al48[+]
 IL-6 Li et al45[ns]
Radojčić et al46[ns]
 TNF-α Li et al45[ns]
Tchetina et al48[+]

Level of evidence: A1=systematic reviews and meta-analyses, based on minimally two independent A2 studies; A2=prospective cohort studies with sufficient sample size and follow-up; adequately controlled for confounding factors and precluding selective loss to follow-up; B=prospective cohort studies, but lacking the quality criteria of A2; retrospective cohort studies and case–control studies; C=non-comparative studies; D=expert opinion. [+] Significant positive association. [ns] Not significant association. [-] Significant negative association.

Level of conclusion: 1=one A1 or at least two independent A2 studies that support each other’s conclusions and do not show conflicting evidence; 2=one A2 or at least two independent B studies that support each other’s conclusions and do not show conflicting evidence; 3=one B or at least two C studies that support each other’s conclusions and do not show conflicting evidence; 4=research at level C or two or more independent studies at higher level that do not support each other’s conclusions and hence, show conflicting evidence; consensus=there is no evidence, but consensus (level D); no conclusions=there is no evidence and no consensus.

BMLs, bone marrow lesions; CRP, C reactive protein; IL, interleukin; TNF-α, tumour necrosis factor-α.